Journal of Alzheimer's Disease
Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies

Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies

Manuscript Number: 

17-1145R1

Author(s): 
David Ames, Prita R. Asih, Anna M. Barron, Prashant R. Bharadwaj, Belinda Brown, Samantha C. Burnham, Ashley I. Bush, Pratishtha Chatterjee, James D. Doecke, Kathryn A. Ellis, W.M.A.D. Binosha Fernando, Paul E. Fraser, Shaun Frost, Stephanie J. Fuller, Sam Gandy, Samantha L. Gardener, Kathryn Goozee, Sunil Gupta, Veer Gupta, Eugene Hone, Simon M. Laws, Wei Ling F. Lim, Ian J. Martins, Ralph N. Martins, Colin L. Masters, Sid E. O’Bryant, Steve Pedrini, Stephanie R. Rainey-Smith, Alan Rembach, Christopher C. Rowe, Olivier Salvado, Tejal Shah, Hamid R. Sohrabi, Kevin Taddei, Giuseppe Verdile, Victor L. Villemagne, Eka J. Wahjoepramono

Source URL: https://www.j-alz.com/manuscript-disclosures/17-1145r1